AMEX:LABD DIREXION DAILY S&P BIOTECH BEAR 3X SHARES
Will be rewarded in a few more weeks.
XBI IBB will continue to uptrend until election focus is on biotech, there is a large misrepresentation of how these companies are valuing drugs. What is the need for a drug when the majority of the population is perfectly healthy? Some drugs are only target less than 1% of the global population so how does that justify making drug companies reach billions of valuation?